World Health Organization Collaborating Centre for HIV Strategic Information, University of Zagreb School of Medicine, Zagreb, Croatia.
World Health Organization Regional Office for Europe, Copenhagen, Denmark.
Euro Surveill. 2022 Feb;27(8). doi: 10.2807/1560-7917.ES.2022.27.8.2100197.
BackgroundEpidemics of sexually transmitted infections (STI) are a major public health challenge in the World Health Organization (WHO) European Region.AimWe aimed to provide an overview of case reporting and other surveillance data for syphilis, gonorrhoea and chlamydia for the non-European Union (EU)/European Economic Area (EEA) countries of the Centre and East part of the WHO European Region as per classification used by the WHO Regional Office for Europe (WHO/Europe) and the European Centre for Disease Prevention and Control.MethodsData were provided by the surveillance agencies of the Member States for the period 2015 to 2019 through the WHO/Europe Communicable Diseases Annual Reporting Form. We analysed reported cases, explored data reported to the WHO Gonococcal Antimicrobial Surveillance Programme (GASP) and performed a review of publications on antimicrobial resistance (AMR) in gonorrhoea in the period 2015 to 2020 using systematic methodology.ResultsFrom 2015 to 2019, in most of the countries with three or more data points, there was a pattern of decrease in reported syphilis, gonorrhoea and chlamydia cases, which is in contrast to the EU/EEA. The number of reported cases per 100,000 population was 0.4-26.5 for syphilis, 0-18.5 for gonorrhoea and 0-43.3 for chlamydia. Four countries reported recent data on AMR in gonorrhoea to GASP, and we identified further publications from Georgia, Russia and Ukraine.ConclusionWe found wide heterogeneity in reported rates of STI. There is a strong need to improve availability and quality of STI surveillance data in the non-EU/EEA countries.
性传播感染(STI)的流行是世界卫生组织(WHO)欧洲区域面临的主要公共卫生挑战。
按照世界卫生组织欧洲区域办事处(WHO/Europe)和欧洲疾病预防控制中心使用的分类,对 WHO 欧洲区域中部和东部非欧盟/欧洲经济区(EU/EEA)国家的梅毒、淋病和衣原体病例报告和其他监测数据进行概述。
成员国的监测机构通过 WHO/Europe 传染病年度报告表,在 2015 年至 2019 年期间提供了数据。我们分析了报告病例,探讨了向 WHO 淋球菌抗菌药物监测计划(GASP)报告的数据,并使用系统方法审查了 2015 年至 2020 年期间淋病抗微生物药物耐药性(AMR)的出版物。
在大多数有三个或更多数据点的国家,2015 年至 2019 年期间报告的梅毒、淋病和衣原体病例呈下降趋势,这与欧盟/EEA 形成了对比。每 10 万人口报告的病例数为梅毒 0.4-26.5、淋病 0-18.5、衣原体 0-43.3。四个国家向 GASP 报告了最近的淋病 AMR 数据,我们还从格鲁吉亚、俄罗斯和乌克兰确定了其他出版物。
我们发现报告的 STI 率存在很大差异。非常有必要改善非欧盟/EEA 国家 STI 监测数据的可获得性和质量。